The Fund’s head of strategy for policy, Harley Feldbaum, said Pfizer had committed to at least that many doses and could increase shipments later if organizations involved show they are able to distribute the pills well, noting most will be available toward the end of the year.
Pfizer has said it will charge less for the drug in lower income countries, but has not disclosed a price. The Global Fund is part of the Access to COVID-19 Accelerator partnership , an effort by governments and NGOs like the World Health Organisation to procure tests, treatments, and vaccines for lower income countries.
Paxlovid is expected to be a key tool in treating COVID-19 after it reduced hospitalisations in high-risk patients by around 90% in a clinical trial. Last month, Pfizer said it expects at least $22 billion in sales of Paxlovid this year, based only on currently signed contracts, noting that the figure could climb much higher as more deals are signed.
We're good here in Africa, please help the other continents.
Thanks but I won't take it
We are talking about RussiaUkraine you are bringing in old news can't they send it to Poland border where there is no mask no social distance why 3rf world countries EU turning into 3rd world countries as well.
Why do they not supply the first world countries... we are okay in our 3rd world countries